929P The efficacy and safety of surufatinib combined with chemotherapy in the first-line treatment of advanced periampullary carcinoma: A single arm, prospective, exploratory clinical study.
Saved in:
| Title: | 929P The efficacy and safety of surufatinib combined with chemotherapy in the first-line treatment of advanced periampullary carcinoma: A single arm, prospective, exploratory clinical study. |
|---|---|
| Authors: | Wang, Q.1 (AUTHOR), Tu, M.2 (AUTHOR), Lu, N.1 (AUTHOR), Xu, D.1 (AUTHOR), Wu, Y.1 (AUTHOR), Jiang, K.1 (AUTHOR) |
| Source: | Annals of Oncology. 2025 Supplement 2, Vol. 36, pS608-S609. 2p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2025.08.1498 |
